5:33 PM
Sep 07, 2012
 |  BC Extra  |  Company News

AZN discontinues AZD2820

Palatin Technologies Inc. (NYSE:PTN) said partner AstraZeneca plc (LSE:AZN; NYSE:AZN) discontinued AZD2820, a melanocortin (MC) receptor partial...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >